Delivery Order SPE2DB20D1100-SPE2DB25FA5Q2
Award Date
2/11/25
Potential Completion Date
2/12/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,831.20 firm fixed-price delivery order is for the supply of 4566691271 - CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of CLOBAZAM 2.5 MG/ML SUSPENSION 120ML. The contract has a ceiling value of $1,567.32 and is a firm fixed-price delivery order with an ultimate completion date of April 20, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $1,686.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565047978 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML. The contract has an ultimate completion date of July 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $5,962.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of 4567254711 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order, with a completion date of February 13, 2025. This award is part of a larger Indefinite Delivery...
This federal contract award, valued at $5,655.37, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of 4564541392 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product, to a location...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,335.58 Firm Fixed Price Delivery Order is for the supply of 4567068821 - CLOBAZAM 10 MG TABLET 100S, with a performance period through January 29, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,930.95 firm fixed-price delivery order is for the supply of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of July 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,856.52 firm fixed-price delivery order is for the supply of 4566748542 - CLOBAZAM 10 MG TABLET 100S, with a period of performance through December 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,325.37 firm fixed-price delivery order is for the supply of 4565218484 CLOBAZAM 10 MG TABLET 100S, with a period of performance through July 23, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract covers the delivery of 4,566,626,397 units of the pharmaceutical product CLOBAZAM 10 MG TABLET 100S, with a ceiling value of $3,324.61. The award has a completion date of December 6, 2024 and was issued on December 5, 2024. This contract does...